Logo image
Designing broad-spectrum anti-HIV-1 gRNAs to target patient-derived variants
Journal article   Open access   Peer reviewed

Designing broad-spectrum anti-HIV-1 gRNAs to target patient-derived variants

Will Dampier, Neil T. Sullivan, Cheng-Han Chung, Joshua Chang Mell, Michael R. Nonnemacher and Brian Wigdahl
Scientific reports, v 7(1), pp 14413-7
31 Oct 2017
PMID: 29089503
url
https://doi.org/10.1038/s41598-017-12612-zView
Published, Version of Record (VoR)CC BY V4.0 Open

Abstract

Multidisciplinary Sciences Science & Technology Science & Technology - Other Topics
Clustered regularly interspaced short palindromic repeats (CRISPR) CRISPR-associated protein 9 (Cas9), including specific guide RNAs (gRNAs), can excise integrated human immunodeficiency virus type 1 (HIV-1) provirus from host chromosomes. To date, anti-HIV-1 gRNAs have been designed to account for off-target activity, however, they seldom account for genetic variation in the HIV-1 genome within and between patients, which will be crucial for therapeutic application of this technology. This analysis tests the ability of published anti-HIV-1 gRNAs to cleave publicly available patient-derived HIV-1 sequences to inform gRNA design and provides basic computational tools to researchers in the field.

Metrics

7 Record Views
30 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Biotechnology & Applied Microbiology
Logo image